Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Mannkind Corp (MNKD)

Mannkind Corp (MNKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,886,322
  • Shares Outstanding, K 275,778
  • Annual Sales, $ 198,960 K
  • Annual Income, $ -11,940 K
  • EBIT $ 54 M
  • EBITDA $ 62 M
  • 60-Month Beta 1.30
  • Price/Sales 9.56
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 52.00% ( +1.17%)
  • Historical Volatility 26.32%
  • IV Percentile 48%
  • IV Rank 19.43%
  • IV High 229.09% on 04/30/24
  • IV Low 9.30% on 10/22/24
  • Put/Call Vol Ratio 0.11
  • Today's Volume 711
  • Volume Avg (30-Day) 2,009
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 85,699
  • Open Int (30-Day) 86,143

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.03
  • Number of Estimates 2
  • High Estimate 0.03
  • Low Estimate 0.03
  • Prior Year 0.01
  • Growth Rate Est. (year over year) +200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.30 +8.49%
on 10/24/24
7.63 -10.35%
on 11/06/24
+0.20 (+3.01%)
since 10/22/24
3-Month
5.28 +29.67%
on 08/27/24
7.63 -10.35%
on 11/06/24
+1.51 (+28.33%)
since 08/22/24
52-Week
3.17 +115.77%
on 02/05/24
7.63 -10.35%
on 11/06/24
+3.19 (+87.40%)
since 11/22/23

Most Recent Stories

More News
MannKind (MNKD) Q3 2024 Earnings Call Transcript

MNKD earnings call for the period ending September 30, 2024.

MNKD : 6.84 (-0.87%)
MannKind: Q3 Earnings Snapshot

MannKind: Q3 Earnings Snapshot

MNKD : 6.84 (-0.87%)
MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update

MNKD : 6.84 (-0.87%)
MannKind to Present at 2024 UBS Healthcare Conference

MNKD : 6.84 (-0.87%)
MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic Diseases

MNKD : 6.84 (-0.87%)
MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024

MNKD : 6.84 (-0.87%)
MannKind (MNKD) Q2 2024 Earnings Call Transcript

MNKD earnings call for the period ending June 30, 2024.

MNKD : 6.84 (-0.87%)
MannKind: Q2 Earnings Snapshot

MannKind: Q2 Earnings Snapshot

MNKD : 6.84 (-0.87%)
"Rule Breaker Investing" Market Cap Game Show: Bill Mann vs. Bill Barker

Our first-ever twin bill.

AAPL : 229.87 (+0.59%)
QCOM : 156.79 (+0.86%)
AMZN : 197.12 (-0.64%)
MNKD : 6.84 (-0.87%)
SNBR : 12.49 (+1.13%)
MANH : 280.40 (+3.13%)
TGTX : 35.07 (+1.51%)
QRVO : 69.25 (+2.03%)
ZM : 85.88 (+5.76%)
WOOF : 4.17 (unch)
VZ : 43.15 (+1.53%)
MCD : 290.28 (+0.63%)
MannKind (MNKD) Q1 2024 Earnings Call Transcript

MNKD earnings call for the period ending March 31, 2024.

MNKD : 6.84 (-0.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder...

See More

Key Turning Points

3rd Resistance Point 7.14
2nd Resistance Point 7.07
1st Resistance Point 6.96
Last Price 6.84
1st Support Level 6.77
2nd Support Level 6.70
3rd Support Level 6.59

See More

52-Week High 7.63
Last Price 6.84
Fibonacci 61.8% 5.93
Fibonacci 50% 5.40
Fibonacci 38.2% 4.87
52-Week Low 3.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar